🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multisensory Processing of Alcohol Cues in Young Adult Binge Drinkers

Recruitingn/aAges 18 Years - 25 YearsAllRochester Institute of Technology
NCT06885190 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Binge drinking is common among young adults and is related to many negative health outcomes including blackouts, risky sex, drunk driving, alcohol use disorder, and liver disease. Understanding whether there are differences in how binge drinkers respond to alcohol-related cues and whether this is related to craving is important for improving interventions and treatments. The proposed study will compare behavioral and neural processing of alcohol and non-alcohol cues in a single sensory modality (vision) with that of cues presented in multiple sensory modalities (vision, touch, and smell) with varying degrees of realistic appearance (images, virtual reality, real objects). Participants will answer questionnaires related to their physical and mental health and recent alcohol and drug use. Those eligible for the study will complete two in-person lab sessions. During both sessions they will

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * ages 18 to 25 years old * meet criteria for either the binge drinker or social drinker groups previously described Exclusion Criteria: * history of head injury involving loss of consciousness of 10+ minutes * colorblindness * hearing, tactile, olfactory or uncorrected vision deficits * history of seizures * neurological disorder diagnosis * mental health history of psychosis or mania * history of alcohol or substance use disorder diagnosis * illicit drug use in the past 30 days * changes to psychotropic medication type or dose in past 3 months
💊

What it tests

  • Presentation of alcohol-related and neutral stimuli
📍

Where

1 site
Rochester Institute of Technology
Rochester, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy